A-Alpha Bio Included on Intelligent Apps 40 List

We’re excited to announce our inclusion in the Intelligent Apps 40 list (#IA40). The list identifies private companies building and enabling applications leveraging modern data science at different stages. IA40 is presented by Madrona, Goldman Sachs, PitchBook, Microsoft, and Amazon. The award recognizes A-Alpha Bio’s machine-learning capabilities for accelerating therapeutic discovery and optimization to improve human health.

Venture investors nominated over 250 companies that they believe will transform and define the next generation of software with application intelligence. This year’s judging panel included a panel of over 50 judges from 40 top-tier venture capital investors. For the final selection, judges applied PitchBook’s new machine-learning model that predicts the probabilities of positive outcomes for private companies after being trained on years of data.   

“Since launching the first IA40 last fall, the pace of interest for investing in innovative companies applying AI/ML in novel ways has steadily increased despite public-market volatility. The 2022 group has raised over $5 billion in the last 10 months. We believe companies leveraging data infrastructure to build AI and ML differentiated products will define the future and we are excited to sponsor this annual initiative,” said Matt McIlwain, managing director, Madrona Ventures. “Congratulations to the team at A-Alpha Bio and we are looking forward to supporting the ecosystem and your progress.” 

For the complete list of the IA40: https://www.ia40.com/the-list